| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.88B | 9.47B | 8.20B | 8.09B | 7.54B | 6.89B |
| Gross Profit | 5.13B | 5.80B | 4.54B | 3.91B | 4.16B | 3.63B |
| EBITDA | 2.97B | 3.65B | 2.80B | 2.13B | 2.32B | 2.33B |
| Net Income | 1.33B | 1.68B | 1.40B | 626.43M | 1.05B | 1.22B |
Balance Sheet | ||||||
| Total Assets | 8.39B | 7.91B | 8.43B | 8.56B | 10.22B | 8.44B |
| Cash, Cash Equivalents and Short-Term Investments | 5.50B | 4.09B | 5.39B | 5.60B | 6.78B | 5.73B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.84B | 3.58B | 3.01B | 1.90B | 2.00B | 1.87B |
| Stockholders Equity | 5.55B | 4.33B | 5.42B | 6.59B | 8.22B | 6.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.55B | 3.70B | 1.51B | 501.49M | 1.21B |
| Operating Cash Flow | 0.00 | 2.62B | 3.73B | 2.34B | 1.55B | 1.97B |
| Investing Cash Flow | 0.00 | -901.51M | -1.65B | -1.47B | -1.03B | -473.51M |
| Financing Cash Flow | 0.00 | -3.02B | -2.30B | -2.12B | 490.54M | 1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥50.69B | 9.37 | ― | 2.81% | 4.47% | 11.37% | |
71 Outperform | ¥7.89B | 42.58 | ― | ― | 11.35% | 160.35% | |
66 Neutral | ¥4.89B | 21.99 | ― | ― | 7.60% | 19.13% | |
63 Neutral | ¥50.73B | 30.20 | ― | 2.06% | 15.45% | -9.67% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | ¥3.62B | -2.76 | ― | ― | 1.78% | -125.35% |